A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb

被引：0
|
作者：
Joy, Stephen T. [1 ]
Henley, Matthew J. [1 ,2 ]
De Salle, Samantha N. [1 ,2 ]
Beyersdorf, Matthew S. [1 ,2 ]
Vock, Isaac W. [1 ,3 ]
Huldin, Allison J. L. [1 ,4 ]
Mapp, Anna K. [1 ,2 ,4 ]
机构：
[1] Joy, Stephen T.
[2] 1,Henley, Matthew J.
[3] 1,De Salle, Samantha N.
[4] 1,Beyersdorf, Matthew S.
[5] 1,Vock, Isaac W.
[6] 1,Huldin, Allison J. L.
[7] 1,2,Mapp, Anna K.
来源：
Mapp, Anna K. (amapp@umich.edu) | 1600年 / American Chemical Society卷 / 143期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Journal article (JA)
引用
收藏
页码：15056 / 15062
相关论文
共 50 条
  • [1] A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb
    Joy, Stephen T.
    Henley, Matthew J.
    De Salle, Samantha N.
    Beyersdorf, Matthew S.
    Vock, Isaac W.
    Huldin, Allison J. L.
    Mapp, Anna K.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (37) : 15056 - 15062
  • [2] Modulation of Myb using a Potent and Selective Dual-Site Inhibitor of CBP/p300 KIX
    Joy, Stephen
    Henley, Matthew
    Beyersdorf, Matthew
    Valdes, Yanira Rodriguez
    Mapp, Anna
    PROTEIN SCIENCE, 2021, 30 : 139 - 140
  • [3] Discovery of a Potent and Selective Covalent p300/CBP Inhibitor
    Mastracchio, Anthony
    Lai, Chunqiu
    Digiammarino, Enrico
    Ready, Damien B.
    Lasko, Loren M.
    Bromberg, Kenneth D.
    McClellan, William J.
    Montgomery, Debra
    Manaves, Vlasios
    Shaw, Bailin
    Algire, Mikkel
    Patterson, Melanie J.
    Sun, Chaohong C.
    Rosenberg, Saul
    Lai, Albert
    Michaelides, Michael R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (05): : 726 - 731
  • [4] Selective inhibition of CBP/p300 HAT
    Sarli, Vasiliki
    Giannis, Athanassios
    CHEMISTRY & BIOLOGY, 2007, 14 (06): : 605 - 606
  • [5] Dual Labeling of the CBP/p300 KIX Domain for 19FNMR Leads to Identification of a New Small-Molecule Binding Site
    Gee, Clifford T.
    Arntson, Keith E.
    Koleski, Edward J.
    Staebell, Rachel Lynn
    Pomerantz, William C. K.
    CHEMBIOCHEM, 2018, 19 (09) : 963 - 969
  • [6] Tax and pCREB bind the KIX domain of CBP/p300 at two distinct sites
    Ramirez, JA
    Mick, J
    Giebler, HA
    Nyborg, JK
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (05) : 500 - 501
  • [7] Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
    Picaud, Sarah
    Fedorov, Oleg
    Thanasopoulou, Angeliki
    Leonards, Katharina
    Jones, Katherine
    Meier, Julia
    Olzscha, Heidi
    Monteiro, Octovia
    Martin, Sarah
    Philpott, Martin
    Tumber, Anthony
    Filippakopoulos, Panagis
    Yapp, Clarence
    Wells, Christopher
    Che, Ka Hing
    Bannister, Andrew
    Robson, Samuel
    Kumar, Umesh
    Parr, Nigel
    Lee, Kevin
    Lugo, Dave
    Jeffrey, Philip
    Taylor, Simon
    Vecellio, Matteo L.
    Bountra, Chas
    Brennan, Paul E.
    O'Mahony, Alison
    Velichko, Sharlene
    Mueller, Susanne
    Hay, Duncan
    Daniels, Danette L.
    Urh, Marjeta
    La Thangue, Nicholas B.
    Kouzarides, Tony
    Prinjha, Rab
    Schwaller, Juerg
    Knapp, Stefan
    CANCER RESEARCH, 2015, 75 (23) : 5106 - 5119
  • [8] Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening
    John V. Frangioni
    Leah M. LaRiccia
    Lewis C. Cantley
    Marc R. Montminy
    Nature Biotechnology, 2000, 18 : 1080 - 1085
  • [9] Molecular characterization of HTLV-1 tax interaction with the KIX domain of CBP/p300
    Ramirez, Julita A.
    Nyborg, Jennifer K.
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 372 (04) : 958 - 969
  • [10] Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening
    Frangioni, JV
    LaRiccia, LM
    Cantley, LC
    Montminy, MR
    NATURE BIOTECHNOLOGY, 2000, 18 (10) : 1080 - 1085
12345